Amdocs Limited $DOX Shares Sold by Wedge Capital Management L L P NC

Wedge Capital Management L L P NC reduced its position in Amdocs Limited (NASDAQ:DOX) by 92.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 57,553 shares of the technology company’s stock after selling 681,702 shares during the period. Wedge Capital Management L L P NC owned 0.05% of Amdocs worth $4,634,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DOX. Scotia Capital Inc. raised its holdings in shares of Amdocs by 3.5% in the 3rd quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock worth $352,000 after purchasing an additional 145 shares during the period. CENTRAL TRUST Co boosted its holdings in Amdocs by 6.1% in the third quarter. CENTRAL TRUST Co now owns 2,741 shares of the technology company’s stock valued at $225,000 after purchasing an additional 158 shares during the last quarter. WealthCollab LLC increased its stake in shares of Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after buying an additional 173 shares during the last quarter. Rossby Financial LCC grew its stake in Amdocs by 39.3% in the third quarter. Rossby Financial LCC now owns 620 shares of the technology company’s stock worth $50,000 after purchasing an additional 175 shares in the last quarter. Finally, Blair William & Co. IL raised its position in shares of Amdocs by 5.5% during the 3rd quarter. Blair William & Co. IL now owns 3,393 shares of the technology company’s stock valued at $278,000 after acquiring an additional 177 shares in the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

Amdocs Stock Performance

DOX stock opened at $64.32 on Monday. The business has a fifty day moving average price of $71.46 and a 200 day moving average price of $77.72. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.06. Amdocs Limited has a fifty-two week low of $63.33 and a fifty-two week high of $95.41. The stock has a market capitalization of $6.94 billion, a price-to-earnings ratio of 12.44, a P/E/G ratio of 1.14 and a beta of 0.42.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. The firm had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The company’s revenue was up 4.1% on a year-over-year basis. During the same period last year, the company earned $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s dividend payout ratio (DPR) is currently 40.81%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on DOX. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Stifel Nicolaus decreased their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Barclays reduced their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Finally, Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.